Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII

W. Anthony Frisella, Lynn H. O'Connor, Carole A. Vogler, Marie Roberts, Steven U. Walkley, Beth Levy, Thomas M. Daly, Mark S. Sands

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

Mucopolysaccharidosis type VII (MPS VII) is a lysosomal storage disease caused by the lack of β-glucuronidase (GUSB) activity. GUSB deficiency leads to the progressive accumulation of undegraded glycosaminoglycans (GAGs) in cells of most tissues, including the brain, and is associated with mental retardation. Reduction of lysosomal storage in the central nervous system and prevention of cognitive dysfunction may require intracranial delivery of a therapeutic agent during the newborn period that provides a continuous source of GUSB. Therefore, we injected recombinant adeno-associated virus encoding human GUSB into both the anterior cortex and the hippocampus of newborn MPS VII mice. Total GUSB activity in the brain approached normal levels by 18 weeks. Although GUSB activity was concentrated near the injection sites, lysosomal distension was reduced in most areas of the brain. In addition to histopathologic evidence of GAG reduction, the previously undescribed accumulation of GM2 and GM3 gangliosides in the brain was also prevented. Furthermore, GUSB expression and reduced lysosomal distension correlated with improvements in cognitive function as measured in the Morris Water Maze test. These findings indicate that localized overexpression of GUSB has positive effects on the pathology and cognitive function and does not have overt toxicity.

Original languageEnglish (US)
Pages (from-to)351-358
Number of pages8
JournalMolecular Therapy
Volume3
Issue number3
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Mucopolysaccharidosis VII
Dependovirus
Cognition
Injections
Brain
Glycosaminoglycans
G(M2) Ganglioside
G(M3) Ganglioside
Mucopolysaccharidosis I
Lysosomal Storage Diseases
Glucuronidase
Intellectual Disability
Hippocampus
Central Nervous System
Pathology
Water

Keywords

  • β-glucuronidase
  • Adeno-associated virus
  • Central nervous system
  • Gene therapy
  • Lysosomal storage diseases
  • Morris water maze

ASJC Scopus subject areas

  • Molecular Biology

Cite this

Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII. / Frisella, W. Anthony; O'Connor, Lynn H.; Vogler, Carole A.; Roberts, Marie; Walkley, Steven U.; Levy, Beth; Daly, Thomas M.; Sands, Mark S.

In: Molecular Therapy, Vol. 3, No. 3, 2001, p. 351-358.

Research output: Contribution to journalArticle

Frisella, W. Anthony ; O'Connor, Lynn H. ; Vogler, Carole A. ; Roberts, Marie ; Walkley, Steven U. ; Levy, Beth ; Daly, Thomas M. ; Sands, Mark S. / Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII. In: Molecular Therapy. 2001 ; Vol. 3, No. 3. pp. 351-358.
@article{cc36e77048fc43c385901e50cb39bacc,
title = "Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII",
abstract = "Mucopolysaccharidosis type VII (MPS VII) is a lysosomal storage disease caused by the lack of β-glucuronidase (GUSB) activity. GUSB deficiency leads to the progressive accumulation of undegraded glycosaminoglycans (GAGs) in cells of most tissues, including the brain, and is associated with mental retardation. Reduction of lysosomal storage in the central nervous system and prevention of cognitive dysfunction may require intracranial delivery of a therapeutic agent during the newborn period that provides a continuous source of GUSB. Therefore, we injected recombinant adeno-associated virus encoding human GUSB into both the anterior cortex and the hippocampus of newborn MPS VII mice. Total GUSB activity in the brain approached normal levels by 18 weeks. Although GUSB activity was concentrated near the injection sites, lysosomal distension was reduced in most areas of the brain. In addition to histopathologic evidence of GAG reduction, the previously undescribed accumulation of GM2 and GM3 gangliosides in the brain was also prevented. Furthermore, GUSB expression and reduced lysosomal distension correlated with improvements in cognitive function as measured in the Morris Water Maze test. These findings indicate that localized overexpression of GUSB has positive effects on the pathology and cognitive function and does not have overt toxicity.",
keywords = "β-glucuronidase, Adeno-associated virus, Central nervous system, Gene therapy, Lysosomal storage diseases, Morris water maze",
author = "Frisella, {W. Anthony} and O'Connor, {Lynn H.} and Vogler, {Carole A.} and Marie Roberts and Walkley, {Steven U.} and Beth Levy and Daly, {Thomas M.} and Sands, {Mark S.}",
year = "2001",
doi = "10.1006/mthe.2001.0274",
language = "English (US)",
volume = "3",
pages = "351--358",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII

AU - Frisella, W. Anthony

AU - O'Connor, Lynn H.

AU - Vogler, Carole A.

AU - Roberts, Marie

AU - Walkley, Steven U.

AU - Levy, Beth

AU - Daly, Thomas M.

AU - Sands, Mark S.

PY - 2001

Y1 - 2001

N2 - Mucopolysaccharidosis type VII (MPS VII) is a lysosomal storage disease caused by the lack of β-glucuronidase (GUSB) activity. GUSB deficiency leads to the progressive accumulation of undegraded glycosaminoglycans (GAGs) in cells of most tissues, including the brain, and is associated with mental retardation. Reduction of lysosomal storage in the central nervous system and prevention of cognitive dysfunction may require intracranial delivery of a therapeutic agent during the newborn period that provides a continuous source of GUSB. Therefore, we injected recombinant adeno-associated virus encoding human GUSB into both the anterior cortex and the hippocampus of newborn MPS VII mice. Total GUSB activity in the brain approached normal levels by 18 weeks. Although GUSB activity was concentrated near the injection sites, lysosomal distension was reduced in most areas of the brain. In addition to histopathologic evidence of GAG reduction, the previously undescribed accumulation of GM2 and GM3 gangliosides in the brain was also prevented. Furthermore, GUSB expression and reduced lysosomal distension correlated with improvements in cognitive function as measured in the Morris Water Maze test. These findings indicate that localized overexpression of GUSB has positive effects on the pathology and cognitive function and does not have overt toxicity.

AB - Mucopolysaccharidosis type VII (MPS VII) is a lysosomal storage disease caused by the lack of β-glucuronidase (GUSB) activity. GUSB deficiency leads to the progressive accumulation of undegraded glycosaminoglycans (GAGs) in cells of most tissues, including the brain, and is associated with mental retardation. Reduction of lysosomal storage in the central nervous system and prevention of cognitive dysfunction may require intracranial delivery of a therapeutic agent during the newborn period that provides a continuous source of GUSB. Therefore, we injected recombinant adeno-associated virus encoding human GUSB into both the anterior cortex and the hippocampus of newborn MPS VII mice. Total GUSB activity in the brain approached normal levels by 18 weeks. Although GUSB activity was concentrated near the injection sites, lysosomal distension was reduced in most areas of the brain. In addition to histopathologic evidence of GAG reduction, the previously undescribed accumulation of GM2 and GM3 gangliosides in the brain was also prevented. Furthermore, GUSB expression and reduced lysosomal distension correlated with improvements in cognitive function as measured in the Morris Water Maze test. These findings indicate that localized overexpression of GUSB has positive effects on the pathology and cognitive function and does not have overt toxicity.

KW - β-glucuronidase

KW - Adeno-associated virus

KW - Central nervous system

KW - Gene therapy

KW - Lysosomal storage diseases

KW - Morris water maze

UR - http://www.scopus.com/inward/record.url?scp=0034986419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034986419&partnerID=8YFLogxK

U2 - 10.1006/mthe.2001.0274

DO - 10.1006/mthe.2001.0274

M3 - Article

C2 - 11273777

AN - SCOPUS:0034986419

VL - 3

SP - 351

EP - 358

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 3

ER -